Industry reports 88 deals worth $11.1B in July 2024: GlobalData
The lifesciences sector also reported 73 VC deals worth $2.5 billion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Beacon Therapeutics
Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space: GlobalData
AGTC-501 is highly anticipated as having the potential to become the first gene therapy specifically indicated for X-linked…